Fig. 2From: Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapyProtein-based constructs used for ImmunoPET and T-cell tracking. This panel points out how the molecular weight (MW) of the different antibody- and peptide-derived probes influence their blood pool clearance, which influences the selection of the right radioisotope for immunoPETBack to article page